genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Marburg virus
      Drug Discovery

      First-In-Human Trial of Marburg Vaccine Shows Promising Results

      Infectious Disease Diagnostics

      Exploring Ways to Block Malaria Transmission

      measles virus
      Infectious Diseases

      Collective Measles Virus Mutations Linked to Fatal Encephalitis

      Bioprocessing

      Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

      Blood cells
      Infectious Diseases

      Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      blood cells
      Blood Disorders

      Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

      Artificial Intelligence

      Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block

      Antibodies

      Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis

      Bioprocessing

      Cell and Gene Therapy Scale-Up Challenges

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Biodefense/Bioterrorism

Biodefense/Bioterrorism

  • 10x Genomics
  • A-Lists
  • AgBio
  • Age-Related Disorders
  • Aging
  • AGTC
  • alcohol
  • Alexandria Real Estate Equities
  • Allergic Diseases
  • Application Notes
  • Artificial Intelligence
  • Autoimmune Disorders
  • Bacterial Diseases
  • Bacteriophage
  • Base Editing
  • Bayer
  • Biodefense/Bioterrorism
  • Bioethics
  • Biomarker Discovery
  • BioNTech
  • BioPerspectives
  • Blockchain
  • Blood Disorders
  • Boehringer Ingelheim
  • Bone disorders
  • Brexit
  • Bristol-Myers Squibb
  • Cardiovascular Disease
  • Careers
  • Celgene
  • Cell Analysis
  • Cell Biology
  • Cell Culture
  • Cell Line Development
  • Cell Signaling
  • Cell Therapy
  • Cellular Analysis
  • China
  • Chromatography
  • Circadian Rhythm
  • Commentary
  • Compound Synthesis
  • Computational Biology
  • Computer Simulation
  • COVID-19 Candidates
  • CRISPR
  • CRISPR/Cas9
  • Danaher
  • Developmental Disorders
  • DNA Repair
  • Drug Resistance
  • Ear Disorders
  • Economic development
  • Education and training
  • Electrophoresis
  • Eli Lilly
  • Employment Trends
  • Endocrine Disorders
  • Evolution
  • Extracellular Matrix
  • Eye Disorders
  • Fill and Finish
  • Financing
  • Flow Cytometry
  • Forensics
  • Fungal Diseases
  • Gastrointestinal Disorders
  • GEN 40
  • GEN Edge
  • Genentech
  • Genetic Disease Testing
  • Genetics
  • Glycan Analysis
  • Glycoproteins
  • GWAS
  • Hematologic Conditions
  • Histology
  • HPLC
  • Hypertension
  • Imaging
  • Immunoassay
  • Immunochemistry
  • Immunology
  • In-vitro Fertilization
  • Industry News
  • Inflammatory Diseases
  • Information Management
  • Insights
  • interleukin
  • Ion Channels
  • Kidney Diseases
  • Kinases
  • Literature Review
  • Liver Diseases
  • Lung Cancer
  • Lung Diseases
  • Magazine
  • Marijuana
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Biodefense/Bioterrorism

    Ukraine to Strengthen Biosecurity with Ginkgo Bioworks Collaboration

    Young women scientist working with petri dish
    Biodefense/Bioterrorism

    New Kansas Commercial/Biodefense Biomanufacturing Facility Planned

    Horizontal DNA Double Helixx
    Biodefense/Bioterrorism

    DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologies

    Biodefense/Bioterrorism

    Intranasal Anthrax Vaccine Candidate “Off to the Races”

    Anthrax bacteria, illustration
    Biodefense/Bioterrorism

    Removing Anthrax Bacterial Armor May Lead to New Therapies

    The most commonly used oral class of antibiotics for urinary tract infections
    Biodefense/Bioterrorism

    Spero Wins Up to $54M Toward Development of Lead Antibiotic SPR994...

    Biodefense/Bioterrorism

    Bavarian Nordic Wins Up-to-$36M DoD Contract toward Equine Encephalitis Vaccine

    Overview of synthetic incompatibility. [Nature Communications 8
    Biodefense/Bioterrorism

    GMO Safety Factor Prevents Fruitful Interbreeding in the Wild

    Biodefense/Bioterrorism

    Bavarian Nordic Wins Up-to-$539M BARDA Contract for Smallpox Vaccine

    Biodefense/Bioterrorism

    Emergent Wins $63M BARDA Contract for Cyanide Antidote Spray Device

    Biodefense/Bioterrorism

    U.S. DOD to Start New Trial with Pluristem’s PLX-R18 Cell Therapy...

    Output from a sequencing machine that was subjected to an attack orchestrated by computer scientists. The attack
    Biodefense/Bioterrorism

    Malware Hidden in Synthetic DNA Could Infect Sequencing Systems

    Biodefense/Bioterrorism

    MerLion, Dstl Score DTRA Grant to Support Biothreat Antibiotic Development

    Biodefense/Bioterrorism

    Emergent Confirms $100M BARDA Contract for Anthrax Vaccine Stockpiling

    Biodefense/Bioterrorism

    Pluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood...

    123...12Page 1 of 12

    Recently Featured

    Exploring Ways to Block Malaria Transmission

    Exploring Ways to Block Malaria Transmission

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up